Treatment Companion App
Prescription-only medicine · New Zealand

The clinical record for ibogaine treatment — before, during and long after the dose.

Ibogaine carries real cardiac risk. This platform holds the whole treatment arc in one record: contraindication screening, QTc and vitals monitoring against protocol-specific intervals, auto-scored assessments, adverse event logging, and integration follow-up out to six months.

8
Delivery-mode protocols
500ms
QTc alert threshold
6mo
Follow-up horizon
5
Assessment instruments

Built around the risk, not around the ceremony

Medication & psychedelic readiness

Medication inventory, substance-specific interaction screening with cited evidence, cardiac and antidepressant readiness review, an 11-stage workflow and documented prescriber decisions. Included in every licence tier.

Screening & intake

Structured contraindication screening — cardiac history, QT-prolonging medications, liver function, substance history — producing a documented cleared, caution or contraindicated decision before any dose is prescribed.

Cardiac safety monitoring

Timed vitals and QTc capture with automatic threshold alerts at 460ms and 500ms, bradycardia below 50bpm, desaturation and hypotension. Alerts are raised in the database, not the browser, so they cannot be missed.

Psychometric assessments

PHQ-9, GAD-7, craving, sleep and mood, auto-scored and banded, charted against treatment milestones so change over the arc of care is visible at a glance.

Delivery-mode protocols

Every combination of route, formulation, dosing strategy and setting maps to its own checklist, vitals interval and observation window — oral and IV ibogaine HCl, sublingual iboga TA, root bark, flood, titrated, booster and microdose.

Adverse events & follow-up

Session records, an adverse event register with actions taken, and scheduled 1-week, 1-month, 3-month and 6-month integration follow-ups with assessment batteries attached.

Deployable in any jurisdiction

Country, timezone, locale, currency, units and regulatory wording are configuration, not code. Metric or imperial, NZ or anywhere else, with the same clinical core.

Multi-language interface

Clinicians and patients can use the whole app in their own language — ten languages including Spanish, Portuguese, Dutch, French, German, Mandarin, Hindi, Arabic, Bengali and Indonesian, with right-to-left support. Included in every licence tier.

Included in every licence tier

Medication & Psychedelic Readiness — the screening step most programmes skip

Patients regularly arrive for ibogaine or other psychedelic treatment while taking antidepressants or other medicines, with no structured screening for interactions, withdrawal history, serotonin-related risk, or cardiac risk. This system makes that screening explicit, evidenced and auditable — on Practitioner, Clinic and Network alike.

Medication disclosure & inventory

Prescription, over-the-counter, supplement, herbal and recreational use with dose, frequency, duration and last-taken date — plus medication list and packaging photo uploads.

Substance-specific interaction screening

Ibogaine, psilocybin, MDMA, ketamine and ayahuasca each screen against a governed rule library, with every flag carrying its evidence source, evidence level, named reviewer and review date.

Cardiac & medical readiness

Arrhythmia, syncope, chest pain, long QT and family sudden-death history from the patient; ECG, QTc, heart rate, BP, electrolytes, liver and kidney results from the clinician.

Antidepressant readiness

Current and previous antidepressants, dose changes, prior withdrawal experience and prescriber contact details, captured for prescriber liaison rather than app-side advice.

Clinician portal & staged workflow

An 11-stage workflow from registration to post-treatment monitoring, with recorded decisions: reviewed, more information required, specialist referral required, or not currently ready.

Reporting, education & audit

One-click readiness report as PDF, serotonin safety education, an emergency plan that localises to your licensed country (national emergency, poisons and crisis lines), and an audit entry for every clinical decision and reviewer.

Educational and clinical-support only. The platform never tells anyone to stop, reduce, substitute or taper a prescription medicine — medication changes are planned and managed by the patient’s prescribing clinician.

Two surfaces, one record

Clinicians get a triage-first roster: risk badge, phase, latest QTc, unacknowledged alerts. Patients get a single daily card — mood, cravings, sleep, symptoms, and home vitals for telehealth microdosing — that writes straight into the same chart the prescriber reads.

  • Row-level access control: patients see only their own record
  • Alerts raised by database triggers, not client-side checks
  • Every reading attributed and timestamped
  • Adverse events recorded against the session that caused them
Roster preview1 critical
Hemi Walker
Treatment day
QTc 486
Sarah Whitcombe
Pre-treatment
QTc 462
Tama Ngata
Follow-up
QTc 408
Daniel Osei
Post-acute
QTc 430

Clinical resources

Practical guidance for prescribers, medical directors and clinic managers running ibogaine treatment — in New Zealand and internationally.

Licence it for your clinic

Three tiers from sole-charge prescriber to multi-region provider network. 21-day trial, no card required to start.

See plans and pricing